Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-141281)

Filing Details

Accession Number:: 0001209191-16-141281
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-13 18:15:20
Reporting Period:: 2016-09-09

Filing Date:: 2016-09-13
Accepted Time:: 2016-09-13 18:15:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591950	Maher Albitar	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-09	9,075	$8.31	156,300	No	4	S	Direct
Common Stock	Disposition	2016-09-12	51,000	$8.21	105,300	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	63,492	Indirect	Shares owned by Albitar Oncology Defined Benefit Plan
Common Stock	165,375	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$7.15	2017-04-20	2021-04-20	200,000	200,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-20	200,000	200,000	Direct

Footnotes

On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.